Clinical Trials
Phase II Clinical Trial currently open for participation:
-------------------------------------------------------------------------------------------------------------------------------------
Study:             NCT04486781                                                                  
Description: A Phase II trial of pembrolizumab as standard of care + sEphB4-HSA in chemotherapy ineligible or                                  chemotherapy refusing patients with metastatic urothelial carcinoma.
For More Information: Sarcoma Oncology Center. Santa Monica, California. Tel: (310)  552-9999
------------------------------------------------------------------------------------------------------------------------------------ 
For Pre-Approval access to sEphB4-HSA, please see our Investigational Drug Expanded Access Policy.